Saturday, December 13, 2025 | 04:46 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India's Covid diplomacy: US to Russia, Delhi part of every vaccine alliance

India is party to Sputnik-V, the vaccine under development jointly by Russia's Gamaleya National Research Institute of Epidemiology and Microbiology and Indian pharma company Dr Reddy's Laboratories

Covid-19 coronavirus
premium

So if the new global currency of power is a vaccine against Covid-19, India’s partner to win the race is Russia. For this could be the first vaccine to hit the market, though it is early yet to say when

Aditi Phadnis New Delhi
From Israel to France and the US to Sweden, if there is any country or alliance in the world that is developing a vaccine against Covid-19, India is part of the effort, marking new frontiers of diplomacy. The exception is China, where Sinovac is developing a vaccine and has chosen Bangladesh as its partner in the region.

“We were not invited (to participate)” said an official in the Ministry of External Affairs.

India is party to Sputnik-V, the vaccine under development jointly by Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology, which reports to the Russian health ministry, and